We are live on ! Find out more
AXLA

Axcella Health Inc. Common Stock

Delisted

AXLA was delisted on the 22nd of November, 2023.

29 hedge funds and large institutions have $23.6M invested in Axcella Health Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

48% more capital invested

Capital invested by funds: $15.9M → $23.6M (+$7.67M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

15% less funds holding

Funds holding: 3429 (-5)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2K

Holders
29
Holders Change
-5
Holders Change %
-14.71%
% of All Funds
0.46%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
7
Reduced
3
Closed
8
Calls
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$3K

AXLA Hedge Fund Activity: Q1 2023 in Review

29 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q1 2023, worth a combined $23.6M — up 48% from $15.9M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of AXLA and 3 opened new positions — a net loss of 5 holders — while 3 trimmed existing stakes and 7 added.

The largest buyer was Geode Capital Management, adding an estimated $52.8K. The largest seller was CAAS Capital Management, cutting an estimated $106K.

  • 29 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q1 2023, down from 34 in Q4 2022.
  • Funds reported $23.6M of Axcella Health Inc. Common Stock stock for Q1 2023, up 48% quarter-over-quarter.
  • 3 funds opened new Axcella Health Inc. Common Stock positions in Q1 2023 and 8 closed out, a net change of -5 holders.
  • The largest Axcella Health Inc. Common Stock buyer in Q1 2023 was Geode Capital Management, an estimated $52.8K added.
  • The largest Axcella Health Inc. Common Stock seller in Q1 2023 was CAAS Capital Management, an estimated $106K sold.

Based on aggregated 13F filings for Q1 2023.